CN Patent

CN117100750A — 一种药物组合物及其应用

Assigned to Shenzhen Salubris Pharmaceuticals Co Ltd · Expires 2023-11-24 · 2y expired

What this patent protects

本发明提供了药物组合应用技术领域，具体涉及一种药物组合物及其应用。所述药物组合物含有氘代右美沙芬或其盐，和安非他酮类药物或其盐。

USPTO Abstract

本发明提供了药物组合应用技术领域，具体涉及一种药物组合物及其应用。所述药物组合物含有氘代右美沙芬或其盐，和安非他酮类药物或其盐。

Drugs covered by this patent

Patent Metadata

Patent number: CN117100750A
Jurisdiction: CN
Classification: —
Expires: 2023-11-24
Drug substance claim: No
Drug product claim: No
Assignee: Shenzhen Salubris Pharmaceuticals Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.